<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27019424</article-id><article-id pub-id-type="pmc">4809614</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0152845</article-id><article-id pub-id-type="publisher-id">PONE-D-16-11759</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nagata</surname><given-names>Eiichiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ogino</surname><given-names>Mieko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iwamoto</surname><given-names>Kounosuke</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kitagawa</surname><given-names>Yasuhisa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iwasaki</surname><given-names>Yasuo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yoshii</surname><given-names>Fumihito</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ikeda</surname><given-names>Joh-E.</given-names></name></contrib><contrib contrib-type="author"><collab>ALS Consortium Investigators</collab></contrib></contrib-group><pub-date pub-type="epub"><day>28</day><month>3</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>3</issue><elocation-id>e0152845</elocation-id><permissions><copyright-statement>&#x000a9; 2016 Nagata et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Nagata et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0152845.pdf"/><related-article id="d36e107" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.1371/journal.pone.0149509">
<article-title>Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients</article-title>
</related-article><counts><fig-count count="0"/><table-count count="0"/><page-count count="1"/></counts></article-meta></front><body><sec id="sec001"><title>Notice of Republication</title><p>This article was republished on March 14, 2016, to correct the captions of Figs 3&#x02013;7 and Figs 9&#x02013;10 and figure citations in the Discussion section. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.</p></sec><sec sec-type="supplementary-material" id="sec002"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0152845.s001"><label>S1 File</label><caption><title>Originally published, uncorrected article.</title><p>(PDF)</p></caption><media xlink:href="pone.0152845.s001.PDF"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0152845.s002"><label>S2 File</label><caption><title>Republished, corrected article.</title><p>(PDF)</p></caption><media xlink:href="pone.0152845.s002.PDF"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>Reference</title><ref id="pone.0152845.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Nagata</surname><given-names>E</given-names></name>, <name><surname>Ogino</surname><given-names>M</given-names></name>, <name><surname>Iwamoto</surname><given-names>K</given-names></name>, <name><surname>Kitagawa</surname><given-names>Y</given-names></name>, <name><surname>Iwasaki</surname><given-names>Y</given-names></name>, <name><surname>Yoshii</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients</article-title>. <source>PLoS ONE</source>
<volume>11</volume>(<issue>2</issue>): <fpage>e0149509</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0149509">10.1371/journal.pone.0149509</ext-link></comment>
<pub-id pub-id-type="pmid">26910108</pub-id></mixed-citation></ref></ref-list></back></article>